| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260905.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029011167 |
Resistant |
| ENSG00000260905.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042456856 |
Resistant |
| ENSG00000260905.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.042139145 |
Sensitive |
